72 related articles for article (PubMed ID: 1298871)
1. [Effect of 5-hydroxytryptophan on the secretion of PRL, GH, TSH and cortisol in obesity].
Martinelli I; Mainini E; Mazzi C
Minerva Endocrinol; 1992; 17(3):121-6. PubMed ID: 1298871
[TBL] [Abstract][Full Text] [Related]
2. Role of the serotonin receptor subtype 5-HT1D on basal and stimulated growth hormone secretion.
Mota A; Bento A; Peñalva A; Pombo M; Dieguez C
J Clin Endocrinol Metab; 1995 Jun; 80(6):1973-7. PubMed ID: 7775648
[TBL] [Abstract][Full Text] [Related]
3. [Effect of calcitonin on the secretion of PRL, TSH, GH, LH, FSH, cortisol, T3 and T4].
Słowińska-Srzednicka J; Zgliczyński S; Jeske W; Rozbicka G; Kaniewski M; Czech W
Endokrynol Pol; 1984; 35(5):267-73. PubMed ID: 6442231
[No Abstract] [Full Text] [Related]
4. Neuroendocrine aberrations in women with functional hypothalamic amenorrhea.
Berga SL; Mortola JF; Girton L; Suh B; Laughlin G; Pham P; Yen SS
J Clin Endocrinol Metab; 1989 Feb; 68(2):301-8. PubMed ID: 2493024
[TBL] [Abstract][Full Text] [Related]
5. Changes in anterior pituitary hormone levels after serotonin 1A receptor stimulation.
Di Sciullo A; Bluet-Pajot MT; Mounier F; Oliver C; Schmidt B; Kordon C
Endocrinology; 1990 Aug; 127(2):567-72. PubMed ID: 2164913
[TBL] [Abstract][Full Text] [Related]
6. Persistent GHRH-induced PRL secretion in Cushing's syndrome, obesity and exogenous hypercortisolism.
Cordido F; Peino R; Martínez-Ramonde T
Rev Esp Fisiol; 1994 Sep; 50(3):139-43. PubMed ID: 7886270
[TBL] [Abstract][Full Text] [Related]
7. Influence of endogenous opiates on anterior pituitary function.
Van Vugt DA; Meites J
Fed Proc; 1980 Jun; 39(8):2533-8. PubMed ID: 6247213
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of serotonin 5-HT(1A) receptor antagonists on the secretion of corticotropin and prolactin.
Jørgensen H; Kjaer A; Warberg J; Knigge U
Neuroendocrinology; 2001 May; 73(5):322-33. PubMed ID: 11399905
[TBL] [Abstract][Full Text] [Related]
9. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine responses to serotonergic agents in alcoholics.
Lee MA; Meltzer HY
Biol Psychiatry; 1991 Nov; 30(10):1017-30. PubMed ID: 1756196
[TBL] [Abstract][Full Text] [Related]
11. Effect of 1-5 hydroxytryptophan infusion on growth hormone and prolactin secretion in man.
Lancranjan I; Wirz-Justice A; Pühringer W; Del Pozo E
J Clin Endocrinol Metab; 1977 Sep; 45(3):588-93. PubMed ID: 302840
[TBL] [Abstract][Full Text] [Related]
12. On the role of dopamine receptors in the naloxone-induced hormonal changes in man.
Delitala G; Devilla L; Musso NR
J Clin Endocrinol Metab; 1983 Jan; 56(1):181-4. PubMed ID: 6847869
[TBL] [Abstract][Full Text] [Related]
13. Paraventricular nucleus mediates prolactin secretory responses to restraint stress, ether stress, and 5-hydroxy-L-tryptophan injection in the rat.
Minamitani N; Minamitani T; Lechan RM; Bollinger-Gruber J; Reichlin S
Endocrinology; 1987 Mar; 120(3):860-7. PubMed ID: 3542515
[TBL] [Abstract][Full Text] [Related]
14. Effects of growth hormone secretagogues on the release of adenohypophyseal hormones in young and old healthy dogs.
Bhatti SF; Duchateau L; Van Ham LM; De Vliegher SP; Mol JA; Rijnberk A; Kooistra HS
Vet J; 2006 Nov; 172(3):515-25. PubMed ID: 15951209
[TBL] [Abstract][Full Text] [Related]
15. Differential ontogeny of opioid, dopaminergic and serotonergic regulation of prolactin secretion.
Bero LA; Kuhn CM
J Pharmacol Exp Ther; 1987 Mar; 240(3):825-30. PubMed ID: 3031276
[TBL] [Abstract][Full Text] [Related]
16. Mirtazapine decreases stimulatory effects of reboxetine on cortisol, adrenocorticotropin and prolactin secretion in healthy male subjects.
Schüle C; Baghai T; Laakmann G
Neuroendocrinology; 2004 Jan; 79(1):54-62. PubMed ID: 14755134
[TBL] [Abstract][Full Text] [Related]
17. Transient effect of L-5-hydroxytryptophan on pituitary function in men and women.
Mashchak CA; Kletzky OA; Spencer C; Artal R
J Clin Endocrinol Metab; 1983 Jan; 56(1):170-6. PubMed ID: 6600170
[TBL] [Abstract][Full Text] [Related]
18. Effect of 5-hydroxytryptophan on prolactin and growth hormone release in the infant rat: evidence for different neurotransmitter mediation.
Cocchi D; Gil-Ad I; Panerai AE; Locatelli V; Müller EE
Neuroendocrinology; 1977; 24(1):1-13. PubMed ID: 23503
[TBL] [Abstract][Full Text] [Related]
19. Growth rate and secretion of pituitary hormones in relation to age and chronic treatment with thyrotropin-releasing hormone in prepubertal dairy heifers.
Davis SL; Sasser RG; Thacker DL; Ross RH
Endocrinology; 1977 May; 100(5):1394-402. PubMed ID: 191244
[TBL] [Abstract][Full Text] [Related]
20. Effect of the dopamine agonist, lergotrile mesylate, on circulating anterior pituitary hormones in man.
Thorner MO; Ryan SM; Wass JA; Jones A; Bouloux P; Williams S; Besser GM
J Clin Endocrinol Metab; 1978 Aug; 47(2):372-8. PubMed ID: 45463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
